Medical News

RSS

USPTO grants patent to Bellacure's drug-free treatment device for arthritis pain

The U.S. Patent and Trademark Office granted a patent today to Bellacure, Inc. for its knee pain treatment device, which was designed to allow the patient to reproducibly apply a therapeutic force that urges the femur and tibia apart on the affected side of the knee at an unmatched intensity level while maximizing force efficiency and minimizing weight (United States Patent 7,662,122).

17 Feb 2010

Ardiem Medical receives non-exclusive license to make and sell neuromodulation devices

Ardiem Medical Inc. has obtained a non-exclusive license to make and sell neuromodulation devices based on intellectual property developed at Case Western Reserve University's Department of Biomedical Engineering and the Functional Electrical Stimulation Center in Cleveland.

17 Feb 2010

Health on the Hill - February 16, 2010

Kaiser Health News staff writer Mary Agnes Carey and Eric Pianin of the Fiscal Times talk with the Kaiser Family Foundation's Jackie Judd about recent events on Capitol Hill. For instance, President Obama has scheduled a bipartisan summit for Feb. 25 to discuss ways to pass health care overhaul legislation this year.

17 Feb 2010

Athersys completes enrollment in phase I MultiStem allogeneic stem cell therapy clinical trial

Athersys, Inc. and Angiotech Pharmaceuticals, Inc. announced that Athersys has completed patient enrollment for its phase I clinical trial of MultiStem(R), its allogeneic stem cell therapy product, administered to individuals following acute myocardial infarction (AMI), more commonly referred to as a heart attack. Top line results of the trial are expected to be announced midyear, upon completion of the four-month patient follow-up visits and analysis of results.

17 Feb 2010

Deficit panel to tackle worries of federal debt, including health spending

The New York Times reports that President Obama's appointment of a special panel to study the nation's debt will come "(a)fter decades of warnings that budgetary profligacy, escalating health care costs and an aging population would lead to a day of fiscal reckoning."

17 Feb 2010

Eat fruits and vegetables to prevent heart disease

As heart disease continues to be the leading cause of death in the United States for all adults, a new report released by the Nutrilite Health Institute, America's Phytonutrient Report: Heart Health by Color*, shows that Americans are falling short on heart-healthy phytonutrients.

17 Feb 2010

COBRA expansion, Medicare payments to doctors 'fix' looming over Congress

Lawmakers seek ways to expand COBRA and address the Medicare doctor payment "fix."

17 Feb 2010

Top health groups increased political spending in 2009

USA Today: "Pharmacists, optometrists and groups representing an array of medical specialists boosted their political giving in 2009, as Congress worked on health care legislation that would dramatically reshape their industry. ... Donations by the top 15 health care political action committees rose to $11.7 million in 2009, a nearly 14% increase from 2007, the most recent non-election year, according to a USA TODAY analysis of data compiled by CQ MoneyLine."

17 Feb 2010

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

Talecris Biotherapeutics announced today that it has received approval from Health Canada for PROLASTIN®-C (Alpha1-Proteinase Inhibitor [Human]), a more purified and concentrated version of PROLASTIN® produced using advances in manufacturing technology. A similar approval for PROLASTIN-C was granted by the U.S. Food and Drug Administration on October 17, 2009.

17 Feb 2010

IH Systems selects Robotic IV Automation Systems for cytotoxic drug preparation

Following the successful integration of RIVA (Robotic IV Automation System) - a self-contained unit for filling IV syringes and bags - into three healthcare institutions in 2009, and the announcements of several more sales for installation in 2010, medical device company Intelligent Hospital Systems has confirmed the sale of three additional RIVA systems for cytotoxic drug preparation in 2010.

17 Feb 2010

White House hints at new health bill as GOP sees possible upside in summit

White House officials "hinted on Tuesday that President Obama might post his own [health care] bill on the Internet before the bipartisan health care summit he is planning" next week, The New York Times reports. "In the nearly a year since Congress began debating a health care overhaul, Mr. Obama has yet to make his own priorities explicit. He said at the outset that he would set broad parameters for the measure and leave the details to lawmakers." Obama said last week that hoped to post to the Internet a merged bill that would address costs and expand coverage.

17 Feb 2010

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

St. David's HealthCare and MedCath Corporation today announced an agreement for St. David's HealthCare to acquire the Heart Hospital of Austin. St. David's HealthCare is a multi-hospital regional healthcare system based in Austin, Texas.

17 Feb 2010

Senesco Technologies announces financial results for quarter ended December 31, 2009

Senesco Technologies, Inc. today reported financial results for the three months ended December 31, 2009.

17 Feb 2010

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

Tioga Pharmaceuticals, Inc. today announced the closing of an $18 million equity financing. Current investors Forward Ventures, New Leaf Venture Partners and BB Biotech Ventures were joined by new investor Genesys Capital Partners.

17 Feb 2010

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Otonomy, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of the company's Investigational New Drug (IND) application for the clinical trial of OTO-104 in patients with Meniere's disease, a debilitating disorder of the inner ear affecting balance and hearing.

17 Feb 2010

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

Marcadia Biotech Inc. today announced that it has initiated a Phase 1 clinical trial of MAR701, a novel dual agonist of the incretin hormone receptors for glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Marcadia plans to initially develop this compound as a treatment for type 2 diabetes with once-weekly dosing. The Phase 1 trial will evaluate MAR701 in healthy volunteers at escalating dose levels.

17 Feb 2010

NABsys to utilize $7M Series B funding for accelerating DNA sequencing platform development

NABsys Inc., the pioneer in electronic, solid-state DNA sequencing, today announced that it has received a $7 million investment as part of a Series B equity round led by Stata Venture Partners. The funding will be used to accelerate the development and commercialization of the company’s proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine.

17 Feb 2010

Wellstar International commences Beta Test in Long Term Care Facility

Wellstar International, Inc. has announced they have started the Beta Test in a Long Term Care Facility.

17 Feb 2010

Pharmatek Laboratories meets DEA requirements for developing and manufacturing controlled substances

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has successfully met Drug Enforcement Agency (DEA) requirements to be registered for the development and manufacture of Schedule IV and V controlled substances.

17 Feb 2010

NMT Medical completes private placement of common stock and warrants for $5.8M

NMT Medical, Inc. today announced that it has completed a private placement of its common stock and warrants to purchase additional shares of common stock to existing and new stockholders for aggregate proceeds of approximately $5.8 million.

17 Feb 2010

Medical News

USPTO grants patent to Bellacure's drug-free treatment device for arthritis pain

Ardiem Medical receives non-exclusive license to make and sell neuromodulation devices

Health on the Hill - February 16, 2010

Athersys completes enrollment in phase I MultiStem allogeneic stem cell therapy clinical trial

Deficit panel to tackle worries of federal debt, including health spending

Eat fruits and vegetables to prevent heart disease

COBRA expansion, Medicare payments to doctors 'fix' looming over Congress

Top health groups increased political spending in 2009

Health Canada approves Talecris Biotherapeutics' PROLASTIN-C for AAT deficiency

IH Systems selects Robotic IV Automation Systems for cytotoxic drug preparation

White House hints at new health bill as GOP sees possible upside in summit

St. David's Healthcare to acquire Texas-based multi-hospital regional healthcare system

Senesco Technologies announces financial results for quarter ended December 31, 2009

Tioga Pharmaceuticals to utilize $18M equity funding for Phase 3 clinical trial of asimadoline

FDA clears Otonomy's IND for clinical trial of OTO-104 in Meniere's disease patients

Marcadia Biotech commences Phase 1 clinical trial of MAR701 for type 2 diabetes

NABsys to utilize $7M Series B funding for accelerating DNA sequencing platform development

Wellstar International commences Beta Test in Long Term Care Facility

Pharmatek Laboratories meets DEA requirements for developing and manufacturing controlled substances

NMT Medical completes private placement of common stock and warrants for $5.8M

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News